Skip to main content
Fig. 4 | BMC Health Services Research

Fig. 4

From: Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country

Fig. 4

Acute care utilization costs for medications. Absolute (A) and relative (B) costs for all medications by discharge diagnosis group is shown. Analgesics and antibbiotics together accounted for most of the absolute and relative costs in all diagnoses. The main medication costs drivers in all combined acute care visits for vaso-occlusive pain were analgesic and anti-inflammatory drugs. *Adjuvants include anti-anxiolytics, folic acid, anti-emetics, anti-allergy medications, erythropoietin, sodium chloride, and sodium bicarbonate

Back to article page